Illimistx
Seoul, KR · 2 known investors
Find your way into Illimistx
Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-Aβ, a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
Investors · 2
Frequently asked questions
- What does Illimistx do?
- Illimis Therapeutics is a biotech company developing therapeutics for intractable diseases, including GAIA-Aβ, a treatment aimed at improving Alzheimer's disease by clearing beta-amyloid via an efferocytosis-based mechanism that avoids the ARIA side effects of existing treatments. The company focuses on translating life science research into medicines for patients.
- Who are Illimistx's investors?
- Illimistx's investors include Aju IB Invesment Corporation, LB Investment.
- Where is Illimistx headquartered?
- Illimistx is headquartered in Seoul, KR.